LOBELIA INFLATA and COUGH

Overview

COUGH is the #3 most commonly reported adverse reaction for LOBELIA INFLATA, manufactured by Boiron. There are 1 FDA adverse event reports linking LOBELIA INFLATA to COUGH. This represents approximately 4.5% of all 22 adverse event reports for this drug.

Patients taking LOBELIA INFLATA who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

COUGH is moderately reported among LOBELIA INFLATA users, representing a notable but not dominant share of adverse events.

Other Side Effects of LOBELIA INFLATA

In addition to cough, the following adverse reactions have been reported for LOBELIA INFLATA:

• ABDOMINAL PAIN UPPER — 1 reports
• BLISTER — 1 reports
• DIARRHOEA — 1 reports
• DRUG LEVEL DECREASED — 1 reports
• ERYTHEMA — 1 reports
• INFECTION — 1 reports
• MOOD ALTERED — 1 reports
• NAUSEA — 1 reports
• OCULAR HYPERAEMIA — 1 reports
• PANNICULITIS — 1 reports

Other Drugs Associated with COUGH

The following drugs have also been linked to cough in FDA adverse event reports:

Does LOBELIA INFLATA cause COUGH?

COUGH has been reported as an adverse event in 1 FDA reports for LOBELIA INFLATA. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is COUGH with LOBELIA INFLATA?

COUGH accounts for approximately 4.5% of all adverse event reports for LOBELIA INFLATA, making it one of the most commonly reported side effect.

What should I do if I experience COUGH while taking LOBELIA INFLATA?

If you experience cough while taking LOBELIA INFLATA, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages